Search | Syneos Health Communications

#1

Best practices for avoiding the novel corona virus are fairly well publicized, but for people who have contracted COVID-19 guidance can be harder to come by.

#2

The Food and Drug Administration (FDA) has approved the use of Veklury (remdesivir) for use in adult and adolescent patients 12 years of age and older for the treatment of COVID-19 in instances that require hospitalization.

#3

At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.

#4

Over the course of the COVID-19 pandemic, information has varied around whether or not – and how severely – children are affected by the virus.

#5

Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.

#6

Though once overwhelmed by the pandemic, many healthcare systems have already restructured themselves after learning critical lessons from COVID-19.

#7

In this Coronavirus Special Edition Series, we’ve talked a lot about the clinical implications of the COVID-19 pandemic.

#8

So, amid the pandemic, Novo Nordisk adjusted their launch to provide support customized for the time of COVID.

#9

Meg Alexander, head of the reputation and risk management practice at Syneos Health, and Jeff Stewart, managing director at Syneos Health Consulting, teamed up with MM&M to discuss implications of COVID-19 and the upcoming US election on drug pricing.

#10

In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.

#11

The J&J COVID-19 vaccine has been approved by the FDA after showing a significant protective effect against severe disease after one dose.

#12

As testing ramps up, contact tracers are working hard to alert citizens of their risk of exposure to COVID-19.

#13

With about 700 million COVID-19 vaccine doses administered across the globe, the return to (relative) normalcy, in many parts of the world, is starting to feel closer and closer.

#14

Sinai Hospital, one of the oldest in the country, knew it needed large-scale innovation to accommodate and care for the influx of patients with COVID-19.

#15

How are payers responding to COVID-19?

#16

As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.

#17

For four years, scientists at MIGAL, the Galilee Research Institute, had been working on a COVID-19 vaccine without knowing it.

#18

Syneos Health surveyed 55 dermatologists to help us track and understand the impact COVID-19 has had on their engagement with telemedicine platforms and field force teams.

#19

Syneos Health conducted three surveys during the months of March and May 2020, and February 2021, to help us track and understand the impact COVID-19 has had on physicians’ engagement with telemedicine platforms and field force teams.

#20

COVID-19 has introduced an era of unprecedented events to industries across the globe.

#21

With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.

#22

COVID-19 has changed the way we think, live, and work.

#23

As you may have read, the Biden administration announced last week that it will support a proposal to temporarily waive certain intellectual property (IP) protections for COVID-19 vaccines and therapies.

#24

Understanding the impact that telemedicine has had on HCP behaviors including prescribing in the changing COVID-19 landscape.

#25

As we continue to navigate these unprecedented times, Syneos Health conducted two surveys during the months of March and May to help us track and understand the impact COVID-19 has had on physicians’ engagement with telemedicine platforms and field force teams.

#26

COVID-19 has accelerated the rate at which we’re seeing change happening around us.

#27

Pharma sales is set to change forever.

#28

Life sciences commercialization in the COVID-19 era and beyond

#29

The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.

#30

The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.

Search Results

Connect

Site

Search Results

Connect

Site

Subscribe to our RSS feed